Physician profile
Joseph E Marakovits
NPI 1548225527
$847.27
in general payments reported to CMS, 2019-2025
16 companies · $97.15 in 2025
The $97.15 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $86.73 · 2021: $99.37 · 2022: $103 · 2023: $16.76 · 2025: $97.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $217.70 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $120.46 | 2019-2025 | |
| Medtronic, INC. | $84.82 | 2021-2023 | Onyx Frontier |
| Astrazeneca Pharmaceuticals Lp | $74.22 | 2019-2021 | |
| Preventice Services, LLC | $73.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.18 | 2019-2022 | |
| Medtronic Vascular, INC. | $50.34 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $27.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.27 | 2019 | |
| Lundbeck LLC | $19.52 | 2019 | |
| Scpharmaceuticals INC. | $16.05 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.96 | 2019 | |
| Biotronik INC. | $15.39 | 2019 | |
| Pfizer INC. | $13.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Marakovits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.